Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1983 1
1987 1
1995 1
1997 1
2003 1
2004 3
2005 2
2007 5
2008 2
2009 1
2010 1
2011 2
2012 4
2013 3
2014 7
2015 9
2016 4
2017 4
2018 9
2019 8
2020 4
2021 12
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
Haemophilia.
Berntorp E, Fischer K, Hart DP, Mancuso ME, Stephensen D, Shapiro AD, Blanchette V. Berntorp E, et al. Among authors: hart dp. Nat Rev Dis Primers. 2021 Jun 24;7(1):45. doi: 10.1038/s41572-021-00278-x. Nat Rev Dis Primers. 2021. PMID: 34168126 Review.
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.
Pipe SW, Leebeek FWG, Recht M, Key NS, Castaman G, Miesbach W, Lattimore S, Peerlinck K, Van der Valk P, Coppens M, Kampmann P, Meijer K, O'Connell N, Pasi KJ, Hart DP, Kazmi R, Astermark J, Hermans CRJR, Klamroth R, Lemons R, Visweshwar N, von Drygalski A, Young G, Crary SE, Escobar M, Gomez E, Kruse-Jarres R, Quon DV, Symington E, Wang M, Wheeler AP, Gut R, Liu YP, Dolmetsch RE, Cooper DL, Li Y, Goldstein B, Monahan PE. Pipe SW, et al. Among authors: hart dp. N Engl J Med. 2023 Feb 23;388(8):706-718. doi: 10.1056/NEJMoa2211644. N Engl J Med. 2023. PMID: 36812434 Clinical Trial.
International consensus recommendations on the management of people with haemophilia B.
Hart DP, Matino D, Astermark J, Dolan G, d'Oiron R, Hermans C, Jiménez-Yuste V, Linares A, Matsushita T, McRae S, Ozelo MC, Platton S, Stafford D, Sidonio RF Jr, Tiede A. Hart DP, et al. Ther Adv Hematol. 2022 Apr 2;13:20406207221085202. doi: 10.1177/20406207221085202. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35392437 Free PMC article. Review.
Individualized PK-based prophylaxis in severe haemophilia.
Dargaud Y, Delavenne X, Hart DP, Meunier S, Mismetti P. Dargaud Y, et al. Among authors: hart dp. Haemophilia. 2018 Mar;24 Suppl 2:3-17. doi: 10.1111/hae.13397. Haemophilia. 2018. PMID: 29543364 Review.
Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Collins PW, Chalmers E, Hart DP, Liesner R, Rangarajan S, Talks K, Williams M, Hay CR; UK Haemophilia Centre Doctors. Collins PW, et al. Among authors: hart dp. Br J Haematol. 2013 Jan;160(2):153-70. doi: 10.1111/bjh.12091. Epub 2012 Nov 15. Br J Haematol. 2013. PMID: 23157203 Free article. No abstract available.
Monoclonal T-cell receptors: new reagents for cancer therapy.
Stauss HJ, Cesco-Gaspere M, Thomas S, Hart DP, Xue SA, Holler A, Wright G, Perro M, Little AM, Pospori C, King J, Morris EC. Stauss HJ, et al. Among authors: hart dp. Mol Ther. 2007 Oct;15(10):1744-50. doi: 10.1038/sj.mt.6300216. Epub 2007 Jul 17. Mol Ther. 2007. PMID: 17637721 Free article. Review.
79 results